Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Conditions
- Stage I Ovarian Cancer AJCC v6 and v7
- Stage IA Fallopian Tube Cancer AJCC v6 and v7
- Stage IB Fallopian Tube Cancer AJCC v6 and v7
- Stage IC Fallopian Tube Cancer AJCC v6 and v7
- Stage II Ovarian Cancer AJCC v6 and v7
- Stage IIA Fallopian Tube Cancer AJCC v6 and v7
- Stage IIB Fallopian Tube Cancer AJCC v6 and v7
- Stage IIC Fallopian Tube Cancer AJCC v6 and v7
- Stage III Ovarian Cancer AJCC v6 and v7
- Stage III Primary Peritoneal Cancer AJCC v7
- Stage IIIA Fallopian Tube Cancer AJCC v7
- Stage IIIB Fallopian Tube Cancer AJCC v7
- Stage IIIC Fallopian Tube Cancer AJCC v7
- Stage IV Fallopian Tube Cancer AJCC v6 and v7
- Stage IV Ovarian Cancer AJCC v6 and v7
- Stage IV Primary Peritoneal Cancer AJCC v7
Interventions
- PROCEDURE: Assessment of Therapy Complications
- DRUG: Carboplatin
- BIOLOGICAL: Filgrastim
- DRUG: Paclitaxel
- OTHER: Pharmacological Study
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
Sponsor
Gynecologic Oncology Group
Collaborators